Kim, H., Burdette, C., An, H. J., Cho, S. H., Kang, S. Y., Lee, M. A., Hwang, I. K., Kim, T. W., Kim, C., Kim, J. G., Hong, J. Y., Choi, M. K., Oh, S. C., Beom, S., Shin, S. J., Geri, J. B., Kim, H. S., Ahn, J. B. (2026). Efficacy and circulating protein biomarkers of second-line aflibercept plus FOLFIRI according to prior bevacizumab or cetuximab treatment in advanced colorectal cancer (KCSG CO21-21).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3566